Dolutegravir Resistance in Mozambique: Insights from a Programmatic HIV Resistance Testing Intervention in a Highly Antiretroviral Therapy-Experienced Cohort

<b>Background</b>: Treatment failure continues to play a role in HIV-related morbidity in Mozambique. Antiretroviral therapy (ART) regimen switches are decided empirically, as HIV genotypic resistance testing (HIV-GT) is unavailable in Mozambique’s public health system. Since 2016, Médecins Sans Fro...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Maria Ruano, Antonio Flores, Aleny Couto, Irénio Gaspar, Sabine Yerly, Ana Gabriela Gutierrez Zamudio, Rosa Bene, Adelina Maiela, Helder Macuacua, Jeff Lane, Florindo Mudender, Edy Nacarapa
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2025-09-01
Serie:	Infectious Disease Reports
Soggetti:	HIV genotypic resistance testing dolutegravir HIV resistance PLWH Mozambique
Accesso online:	https://www.mdpi.com/2036-7449/17/5/123
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!